Skip to content

Comparison between dexamethasone and methylprednisolone in treatment of COVID-19

Comparison between intravenous dexamethasone and methylprednisolone in treatment of hospitalized patient with COVID-19

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210223050466N1
Enrollment
140
Registered
2021-03-27
Start date
2021-03-21
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 disease. COVID-19

Interventions

Intervention 1: Intervention group 1: hospitalized patients with COVID-19 who take 60 mg intravenous Methylprednisolone in two divided dose, maximum 10 days in addition to standard treatment. Interve

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patient with COVID-19 Under 80 y/o age With positive RT-PCR test With bilateral lung parenchyma infiltration Blood oxygen saturation <93% Did not take any medication or hospitalization for COVID-19 Taking any Corticosteroid They have tendency to participate in this study

Exclusion criteria

Exclusion criteria: Patient leave hospital before discharge Patient who expire in first 24 hour after admission Patient with myocardial infarction during hospitalization Patient with underlying disease who have contraindication of corticosteroid such as acute hepatitis, fungal infection All patient who disagree to continue the study

Design outcomes

Primary

MeasureTime frame
Blood oxygen saturation. Timepoint: In admission. Method of measurement: pulse oxymeter.;Duration of hospitalization. Timepoint: From admission to discharge. Method of measurement: Obsevation.;Duration between onset of symptom to start of corticosteroid. Timepoint: Before admission to start of drug. Method of measurement: Patient history.

Secondary

MeasureTime frame
Mortality rate after 28 day. Timepoint: From admission to 28 day later. Method of measurement: Observation.;Number of oxygen dependency days. Timepoint: From admission to oxygen dependency time. Method of measurement: Observation.;Number of patient who need ICU admission. Timepoint: During hospitalization. Method of measurement: Obsevation.;Lab data. Timepoint: During admission , hospitalization and discharge. Method of measurement: Laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarziyeh dehghani

Shahre-kord University of Medical Sciences

marziehds@gmail.com+98 38 3352 2940

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 12, 2026